Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-22

Clinical Trial Update: Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing wound infiltration with ketamine versus dexmedetomidine added to bupivacaine and its effect on cytokines in patients with endom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)
  • Ketamine (ketamine)

Snippet

Sponsor: Assiut University | Conditions: Endometrial Adenocarcinoma | Phase 4 | Status: COMPLETED